View on Pubmed.gov 23664135 | View on doi.org 10.1016/j.it.20...
Cell type-specific function of TAK1 in innate immune signaling.
- Center for Inflammation and Epigenetics, The Methodist Hospital Research Institute, 6670 Bertner Avenue, Houston, TX 77030, USA.
Abstract
Transforming growth factor β-activated kinase 1 (TAK1 or MAP3K7) is a key signaling component of nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways. Activation of TAK1 is tightly regulated through its binding partners and protein modifications. Although TAK1 functions as an essential and positive regulator of innate immune signaling and apoptosis in mouse embryonic fibroblasts (MEFs), T cells, and other cells, it negatively regulates cell development and activation of proinflammatory signaling pathways in neutrophils. However, the molecular mechanisms responsible for the opposite roles of TAK1 in different cell types remain to be addressed. In this article, we discuss the latest progresses in our understanding of TAK1 regulation, function, and mechanisms in a cell-type specific manner.
References
Cited by 336 citations (total)
Journal Article
Expression of TAK1/TAB1 expression in non-small cell lung carcinoma and adjacent normal tissues and their clinical significance.
Electronic publication date November 1, 2016
Jiang Zhu [...] Guang-Yuan Liu et al.
The purpose of this study was to investigate the expression of transforming growth factor beta-activated kinase 1 (TAK1) and its...
Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.
Photoreceptor Cells Produce Inflammatory Mediators That Contribute to Endothelial Cell Death in Diabetes.
Electronic publication date May 23, 2017
Deoye Tonade [...] Timothy S Kern et al.
PURPOSE
Recent studies suggest that photoreceptor cells regulate local inflammation in the retina in diabetes. The purpose of this study was...
Conflict of interest statement
MeSH
- •
Specialties
- •
Substances
- •
- •
- •
Copyright
Copyright © 2013 Elsevier Ltd. All rights reserved.